Skip to main content

Tryvio Side Effects

Generic name: aprocitentan

Medically reviewed by Drugs.com. Last updated on Jun 10, 2025.

Note: This document provides detailed information about Tryvio Side Effects associated with aprocitentan. Some dosage forms listed on this page may not apply specifically to the brand name Tryvio.

Applies to aprocitentan: oral tablets film-coated.

Important warnings This medicine can cause some serious health issues

    Fetal/Neonatal Morbidity and Mortality
  • Based on animal data, may cause fetal harm during pregnancy.1

  • Exclude pregnancy in females of childbearing potential prior to treatment initiation and prevent thereafter by using acceptable methods of contraception during and for 1 month after discontinuation of therapy.1

  • When pregnancy is detected, discontinue aprocitentan as soon as possible.1

Side effects include:

Adverse effects reported in ≥2% of patients receiving aprocitentan (the active ingredient contained in Tryvio) include edema/fluid retention and anemia.

For healthcare professionals

Applies to aprocitentan: oral tablet.

General adverse events

The most frequently reported side effects included anemia, edema, and fluid retention.[Ref]

Dermatologic

Hematologic

Hepatic

Hypersensitivity

Hypersensitivity included rash, erythema, and allergic edema.

Metabolic

Renal

References

1. (2024) "Product Information. Tryvio (aprocitentan)." Idorsia Pharmaceuticals US Inc.

Does Tryvio interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Further information

Tryvio side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.